Qelbree

Summary : Qelbree (i.e. SPN-812) is a nonstimulant ADHD medication containing a serotonin norepinephrine modulating agent approved by the FDA to treat attention deficit…

US FDA’s Center for Drug Evaluation and Research (CDER) – Novel Drug Approvals for 2021 Innovation drives progress. When it comes to…